Skip to main content
Top
Published in: Molecular Imaging and Biology 1/2006

01-01-2006 | Research Article

Reduction of Brown Fat 2-Deoxy-2-[F-18]fluoro-d-glucose Uptake by Controlling Environmental Temperature Prior to Positron Emission Tomography Scan

Authors: Carlos A. Garcia, MD, Douglas Van Nostrand, MD, F. Atkins, E. Acio, C. Butler, G. Esposito, K. Kulkarni, M. Majd

Published in: Molecular Imaging and Biology | Issue 1/2006

Login to get access

Abstract

 

Brown fat uptake of 2-deoxy-2-[F-18]fluoro-d-glucose (FDG) on a positron emission tomography (PET) scan limits the ability to assess for cancer. Drugs such as benzodiazepine, propranolol, and reserpine have been proposed to reduce this uptake, but the studies have been either small clinical or preclinical trials. As an alternative, we evaluated the effect of controlling the patient’s environmental temperature on brown fat uptake of FDG.

Method

From January 1, 2002 to November 30, 2004, patients were identified who had (1) a pattern of FDG uptake in the neck/paravertebral areas suggestive of brown fat, (2) a repeat FDG-PET scan after control of the patient’s environmental temperature, and (3) no evidence of cancer in the neck/paravertebral areas by other diagnostic methods. For the follow-up PET scan, all patients wore warm clothing and avoided exposure to cold air during their transit to our facility. After arrival, patients were kept in a separate temperature-controlled room (at least 75°F) for 15 minutes to two hours before FDG injection as well as during the uptake phase. Four physicians blindly and retrospectively assessed the FDG uptake in the neck and paravertebral regions on all initial and temperature-controlled PET scans by visually grading the radioactivity on a semiquantitative scale (0 = background, 1+ = background but <liver, 2+ = equal to liver, 3+ >liver). The changes in maximal SUVs were determined in the left and right neck region. Data were evaluated using a two-tail t-test.

Results

Ten patients met the above criteria. The median age was 32 years with a range of 11–58 years. In comparing the semiquantitative uptake and the SUVs of FDG in the neck and paravertebral areas on the initial PET scan to the temperature-controlled PET scan, the mean decrease and the standard deviation of the decrease demonstrated a statistically significant decrease in with P values range from <0.02 to <0.001.

Conclusion

Controlling the patient’s environmental temperature prior to the dosing and during the uptake phase can significantly reduce FDG uptake in brown fat in the neck and paravertebral areas. Further studies are warranted to determine the most effective protocol to control the patient’s environmental temperature in order to minimize brown fat uptake.
Literature
1.
go back to reference Cohade C, Osman M, Pannu H, Wahl R (2003) Uptake in supraclavicular area fat (“USA-Fat”): Description on 18F-FDG PET/CT. J Nucl Med 44:170–176PubMed Cohade C, Osman M, Pannu H, Wahl R (2003) Uptake in supraclavicular area fat (“USA-Fat”): Description on 18F-FDG PET/CT. J Nucl Med 44:170–176PubMed
2.
go back to reference Yeung H, Grewal R, Gonen M, Schoder H, Larson S (2003) Patterns of 18F-FDG uptake in adipose tissue and muscle: A potential source of false positives for PET. J Nucl Med 44:1789–1796PubMed Yeung H, Grewal R, Gonen M, Schoder H, Larson S (2003) Patterns of 18F-FDG uptake in adipose tissue and muscle: A potential source of false positives for PET. J Nucl Med 44:1789–1796PubMed
3.
go back to reference Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK (2002) Brown adipose tissue: A factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29:1393–1398CrossRefPubMed Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK (2002) Brown adipose tissue: A factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29:1393–1398CrossRefPubMed
4.
go back to reference Gordon B, Flanagan F, Dehdashti F (1997) Whole-body positron emission tomography: Normal variations, pitfalls, and technical considerations. AJR 169:1675–1680PubMed Gordon B, Flanagan F, Dehdashti F (1997) Whole-body positron emission tomography: Normal variations, pitfalls, and technical considerations. AJR 169:1675–1680PubMed
5.
go back to reference Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, Podoloff DA, Macapinlac HA (2004) Focal FDG uptake in mediastinal brown fat mimicking malignancy: A potential pitfall resolved on PET/CT. Am J Roentgenol 183:1127–1132 Truong MT, Erasmus JJ, Munden RF, Marom EM, Sabloff BS, Gladish GW, Podoloff DA, Macapinlac HA (2004) Focal FDG uptake in mediastinal brown fat mimicking malignancy: A potential pitfall resolved on PET/CT. Am J Roentgenol 183:1127–1132
6.
go back to reference Minotti AJ, Shah K, Keller K (2004) Positron emission tomography/computed tomography fusion imaging in brown adipose tissue. Clin Nucl Med 29:4–11CrossRef Minotti AJ, Shah K, Keller K (2004) Positron emission tomography/computed tomography fusion imaging in brown adipose tissue. Clin Nucl Med 29:4–11CrossRef
7.
go back to reference Barrington S, Maisey M (1996) Skeletal muscle uptake of Fluorine-18-FDG: Effect of oral diazepam. J Nucl Med 37:1127–1129PubMed Barrington S, Maisey M (1996) Skeletal muscle uptake of Fluorine-18-FDG: Effect of oral diazepam. J Nucl Med 37:1127–1129PubMed
8.
go back to reference Cohade C, Mourtzikos K, Wahl R (2003) “USA-Fat”: Prevalence is related to ambient outdoor temperature—evaluation with 18F-FDG PET/CT. J Nucl Med 44:1267–1270PubMed Cohade C, Mourtzikos K, Wahl R (2003) “USA-Fat”: Prevalence is related to ambient outdoor temperature—evaluation with 18F-FDG PET/CT. J Nucl Med 44:1267–1270PubMed
9.
go back to reference Garcia CA, Van Nostrand D, Majd M, Atkins F, Acio E, Sheikh A, Butler C (2004) Benzodiazepine-resistant “brown fat” pattern in positron emission tomography: Two case reports of resolution with temperature control. Mol Imaging Biol 6:368–372CrossRefPubMed Garcia CA, Van Nostrand D, Majd M, Atkins F, Acio E, Sheikh A, Butler C (2004) Benzodiazepine-resistant “brown fat” pattern in positron emission tomography: Two case reports of resolution with temperature control. Mol Imaging Biol 6:368–372CrossRefPubMed
10.
go back to reference Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL (2004) Intense 18F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 45:1189–1193PubMed Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL (2004) Intense 18F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 45:1189–1193PubMed
11.
go back to reference Wolfgang A, Weber MD (2004) Brown adipose tissue and nuclear medicine imaging. J Nucl Med 45:1101–1103PubMed Wolfgang A, Weber MD (2004) Brown adipose tissue and nuclear medicine imaging. J Nucl Med 45:1101–1103PubMed
Metadata
Title
Reduction of Brown Fat 2-Deoxy-2-[F-18]fluoro-d-glucose Uptake by Controlling Environmental Temperature Prior to Positron Emission Tomography Scan
Authors
Carlos A. Garcia, MD
Douglas Van Nostrand, MD
F. Atkins
E. Acio
C. Butler
G. Esposito
K. Kulkarni
M. Majd
Publication date
01-01-2006
Publisher
Springer-Verlag
Published in
Molecular Imaging and Biology / Issue 1/2006
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-005-0030-3

Other articles of this Issue 1/2006

Molecular Imaging and Biology 1/2006 Go to the issue